References
- Eidson M, Philen R M, Sewell C M, Voorhees R, Kilbourne E M. L‐tryptophan and eosinophilia‐myalgia syndrome in New Mexico. Lancet 1990; 335: 645–648, [PUBMED], [INFOTRIEVE]
- Shapiro S. Epidemiologic studies of the association of L‐tryptophan with the eosinophilia‐myalgia syndrome: a critique. J Rheumatol 1996; 23(suppl 46)44–59
- Horwitz R I, Daniels S R. Bias or biology: evaluating the epidemiologic studies of L‐tryptophan and the eosinophilia‐myalgia syndrome. J Rheumatol 1996; 23(suppl 46)60–72
- Spitzer W O, Haggerty J I, Berkson L, Davis W, Palmer W, Tamblyn R, Laprise R, Mulder L J. Analysis of centers for disease control and prevention criteria for the eosinophilia‐myalgia syndrome in a geographically defined population. J Rheumatol 1996; 23(suppl 46)73–80
- Chan M TS, Leung D YM, Szefler S J. Difficult‐to‐control asthma: clinical characteristics of steroid‐insensitive asthma. J Allergy Clin Immunol 1998; 101: 594–601, [PUBMED], [INFOTRIEVE]
- Malmstrom K, Rodriquez‐Gomez G, Guerra J, Villaran C, Pineiro A, Wei L X, Seidenberg B C, Reiss T F. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized controlled trial. Ann Intern Med 1999; 130: 487–495, [PUBMED], [INFOTRIEVE]
- Szefler S J, Martin R J, King T S, Boushey H A, Cherniak R M, Chinchilli V M, Craig T J, Dolovich M, Drazen J M, Fagan J K, Fahy J V, Fish J E, Ford J G, Israel E, Kiley J, Kraft M, Lazarus S C, Lemanske R F, Jr, Mauger E, Peters S P, Sorkness C A. for the Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109: 410–418, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Martin R J, Szefler S J, Chinchilli V M, Kraft M, Dolorich M, Boushey H A, Cherniak R M, Craig T J, Drazen J M, Fagan J K, Fahy J V, Fish J E, Ford J G, Israel E, Kunselman S J, Lazarus S C, Lemanske R F, Jr, Peters S P, Sorkness C A. Of the National Heart, Lung, and Blood Institute. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002; 165(10)1377–1383, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Fox A F, Collier P F. Low mortality rates in industrial cohort studies due to selection for work and survival in the industry. Br J Prev Soc Med 1976; 30: 225–230, [PUBMED], [INFOTRIEVE]
- Wang J D, Miettinen O S. Occupational mortality studies: principles of validity. Scand J Work, Environ & Health 1982; 8: 153–158
- Hill A, Roberts J, Ewings P, Gunnell D. Non‐response bias in a life‐style survey. J Public Health Med 1997; 19: 203–207, [PUBMED], [INFOTRIEVE]
- Macera C A, Jackson K L, Davis D R, Kronenfeld J J, Blair S N. Patterns of non‐response to a mail survey. J Clin Epidemiol 1990; 43(12)1427–1430, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Etter J F, Perneger T V. Analysis of non‐response bias in a mailed health survey. J Clin Epidemiol 1997; 50: 1123–1128, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hara M, Sasaki S, Sobue T, Yamamoto S, Tsugane S, for JPHC Study Group. Comparison of cause‐specific mortality between respondents and nonrespondents in a population‐based prospective study: ten‐year follow‐up of JPHC study cohort I. J Clin Epidemiol 2002; 55: 150–156, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Benfante R, Reed D, MacLean C, Kagan A. Response bias in the Honolulu heart program. Am J Epidemiol 1989; 130(6)1088–1100, [PUBMED], [INFOTRIEVE]
- The Coronary Drug Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980; 303: 1038–1041